Midkine promotes thyroid cancer cell migration and invasion by activating the phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin pathway
Abstract Objective: Thyroid cancer (TC) therapy, which is routinely used at present, can improve patients’ survival rates. However, lymph node…